Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Fenhuma 200 microgram sublingual tablets

Active Ingredient:
fentanyl citrate
Company:  
Glenmark Pharmaceuticals Europe Ltd See contact details
ATC code: 
N02AB03
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Fenhuma — Patient and Carer guide Important risk minimisation information on Fenhuma® (fentanyl citrate) sublingual tablets for patients prescribed Fenhuma® and their carers.

Fenhuma — Patient and Carer guide

Important risk minimisation information on Fenhuma® (fentanyl citrate) sublingual tablets for patients prescribed Fenhuma® and their carers.

{pdf_link}

Fenhuma — Prescriber Guide Important risk minimisation information on Fenhuma® (fentanyl citrate) sublingual tablets for physicians.

{healthcare_pro_orange} For Healthcare Professionals

Fenhuma — Prescriber Guide

Important risk minimisation information on Fenhuma® (fentanyl citrate) sublingual tablets for physicians.

{pdf_link}

Pharmacist Guide — Important risk minimisation information on Fenhuma® (fentanyl citrate) sublingual tablets for pharmacists.

{healthcare_pro_orange} For Healthcare Professionals

Fenhuma — Pharmacist Guide

Important risk minimisation information on Fenhuma® (fentanyl citrate) sublingual tablets for pharmacists.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Glenmark Pharmaceuticals Europe Ltd
Company image
Address
Building 2, Croxley Park, Watford, WD18 8YA
Telephone
+44 (0)1923 202 950
Fax
+44 (0)1923 251137
Medical Information Direct Line
0800 458 0383
E-mail
[email protected]
Stock Availability
+44 (0)1923 202 950
WWW
www.glenmarkpharma.com